Page last updated: 2024-10-29

ioversol and Cancer of Esophagus

ioversol has been researched along with Cancer of Esophagus in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Xu, X1
Wu, Z1
Zhang, N1
Guo, Z1
Song, T1
Shen, YG1
Jiao, NN1
Li, XH1
Hu, HT1
Qu, JR1
Chen, XJ1
Feng, W1
Zhang, X1
Li, HL1
Ganeshan, DM1
Bhosale, P1
Munden, RF2
Hofstetter, WL1
Correa, AM1
Iyer, R1
Mawlawi, O1
Erasmus, JJ1
Pan, T1
Knight, AE1
Macapinlac, HA1
Podoloff, DA1
Chasen, M1

Trials

1 trial available for ioversol and Cancer of Esophagus

ArticleYear
Selection of dilution material for non-iodinated iodine as an oral contrast agent for esophageal cancer: a preliminary clinical trial.
    Japanese journal of radiology, 2022, Volume: 40, Issue:11

    Topics: Contrast Media; Esophageal Neoplasms; Humans; Iodine; Powders; Sensitivity and Specificity

2022

Other Studies

3 other studies available for ioversol and Cancer of Esophagus

ArticleYear
Esophageal squamous cell carcinoma: assessing tumor angiogenesis using multi-slice CT perfusion imaging.
    Digestive diseases and sciences, 2012, Volume: 57, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Esophageal Neoplasms; Fema

2012
Diaphragmatic hernia after esophagectomy for esophageal malignancy.
    Journal of thoracic imaging, 2013, Volume: 28, Issue:5

    Topics: Adult; Aged; Contrast Media; Esophageal Neoplasms; Esophagectomy; Female; Hernia, Diaphragmatic; Hum

2013
Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation.
    AJR. American journal of roentgenology, 2006, Volume: 186, Issue:2

    Topics: Contrast Media; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenou

2006